Status:
COMPLETED
Intravenous Interferon During Liver Transplant
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
American College of Gastroenterology
Conditions:
Hepatitis C
Cirrhosis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The main goal of this study is to prevent liver allograft infection with Hepatitis C virus in hepatitis C positive patients undergoing liver transplantation. The hypothesis is that patients who receiv...
Detailed Description
The study is evaluating intravenous interferon given during the anhepatic phase of lvier transplant. Ribavirin was given as well. Serial measurements for HCV RNA were determined 12, 24 72, 96 hrs and ...
Eligibility Criteria
Inclusion
- liver transplant for hepatitis c
Exclusion
- allergy to interferon
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01192698
Start Date
October 1 2009
End Date
February 1 2013
Last Update
April 21 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.